| # | Drug | Count |
|---|---|---|
| 0 | HALOPERIDOL LACTATE | 63 |
| 1 | RISPERIDONE | 63 |
| 2 | HALOPERIDOL | 60 |
| 3 | QUETIAPINE | 60 |
| 4 | CLOZAPINE | 49 |
| 5 | ARIPIPRAZOLE | 40 |
| 6 | LORAZEPAM | 40 |
| 7 | OLANZAPINE | 34 |
| 8 | ARIPIPRAZOLE ORAL | 32 |
| 9 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE NASAL | 2 | 0.0308 |
| 1 | ZIPRASIDONE | 13 | 0.0036 |
| 2 | CHLORPROMAZINE HYDROCHLORIDE | 3 | 0.0031 |
| 3 | DEXMEDETOMIDINE | 10 | 0.0029 |
| 4 | COCAINE HYDROCHLORIDE | 1 | 0.0026 |
| 5 | HALOPERIDOL LACTATE | 63 | 0.0025 |
| 6 | DANTROLENE SODIUM | 2 | 0.0017 |
| 7 | HALOPERIDOL DECANOATE | 2 | 0.0011 |
| 8 | ZIPRASIDONE HCL | 3 | 0.0011 |
| 9 | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 185 |
| 1 | Benzodiazepine [EPC] | 83 |
| 2 | Typical Antipsychotic [EPC] | 60 |
| 3 | Central alpha-2 Adrenergic Agonist [EPC] | 31 |
| 4 | Opioid Agonist [EPC] | 27 |
| 5 | Corticosteroid [EPC] | 22 |
| 6 | Anti-epileptic Agent [EPC] | 16 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 16 |
| 8 | General Anesthetic [EPC] | 13 |
| 9 | Mood Stabilizer [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Typical Antipsychotic [EPC] | 60 | 0.0024 |
| 1 | Central alpha-2 Adrenergic Agonist [EPC] | 31 | 0.0006 |
| 2 | Atypical Antipsychotic [EPC] | 185 | 0.0004 |
| 3 | Influenza A M2 Protein Inhibitor [EPC] | 5 | 0.0003 |
| 4 | General Anesthetic [EPC] | 13 | 0.0003 |
| 5 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 6 | Melatonin Receptor Agonist [EPC] | 2 | 0.0002 |
| 7 | Nonergot Dopamine Agonist [EPC] | 2 | 0.0001 |
| 8 | Benzodiazepine [EPC] | 83 | 0.0001 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 16 | 0.0001 |